An interventional study of dietary intervention in Dietary Habits, sponsored by Brigham and Women's Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 333 studies in Feeding Behavior with a site in United States — 46 open to participants now, 66 under way, 1 of them phase 3. Feeding Behavior · United States.
Among the 333 studies in Feeding Behavior with a site in United States, this one is the 226th largest by planned enrollment of the 271 interventional ones that give a count, is one of 33 that started in 2023, is one of 260 with no phase, reaches primary completion later than 25 of the 65 other live ones, and was the 199th registered.
988 studies on the registry are indexed under Feeding Behavior; 177 are open to participants now.
Browse Feeding Behavior studies →46 of the 333 studies in Feeding Behavior with a site in United States are open now. Recruiting first, the newest first:
Cornell University · Sites in United States
Ages 20–60
Arizona State University · Sites in United States
Ages 6 mo–12 mo · Healthy volunteers
Pennington Biomedical Research Center · Sites in United States
Ages 8–12 · Healthy volunteers
University of Texas at Austin · Sites in United States
Ages 30–60 · Women only · Healthy volunteers
Weill Medical College of Cornell University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 112 Feeding Behavior studies recruiting now, 35 (31%) set no upper age limit and 71 (63%) stop at 75 or younger; 41 take children under 18; 70 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
333 studies; the count open now beside each. This study's row is marked.
First in 1984; this study’s year is marked. 33 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 24 is below the median of 79 across 700 interventional studies indexed under Feeding Behavior.
Median enrollment 61 across the 271 interventional studies, 111 across the 62 observational. Of the 250 that completed or were terminated, 58 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 333 have an industry lead sponsor. The 10 most frequent:
Brigham and Women's Hospital is the lead sponsor of 1,270 studies on the registry; 230 are open to participants now.
Of its 117 completed or terminated interventional studies of FDA-regulated products, 65 (56%) have results posted.
Brigham and Women's Hospital has 6 studies filed under Feeding Behavior — fewer than ten, so there is no comparison to draw.
29 of the studies in Feeding Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07290179Pennington Biomedical Research CenterEvaluating the Validity and Feasibility of a Smartwatch-based Eating Detection System to Passively and Automatically Detect Eating Events in Child-parent Dyads | 2026-11 |
| NCT05381766NYU Langone HealthBuilding Access to Food Through Systems and Solidarity | 2026-11-30 |
| NCT06864208The Miriam HospitalAddressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial | 2026-12 |
| NCT03783507The University of Tennessee, KnoxvilleFoods Within a Meal and Food Liking Study | 2026-12 |
| NCT05943626University of UtahCircadian Intervention to Improve Cardiometabolic Health | 2026-12 |
Add all 29 to your calendar (.ics) → With an account.
Among the 333 studies in Feeding Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to test whether our dietary intervention can prevent or lessen the negative health effects of night shift work in healthy participants.
Participants will:
Shift work increases the risk for diabetes possibly due to the adverse metabolic effects of circadian misalignment. As shift work is not foreseen to disappear, the development of individually-targeted therapies for metabolic health in these vulnerable shift workers is urgently needed. This research will determine whether our dietary intervention can mitigate the adverse metabolic effects of circadian misalignment, which may help in the design of evidence-based dietary interventions to improve the metabolic health in shift workers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Control condition first, then the Dietary intervention. Since this is a single blind study, the details of the dietary interventions cannot be released during recruitment stage but will be made public once enrollment closes.
Behavioral: dietary intervention
Dietary intervention first, then the Control condition. Since this is a single blind study, the details of the dietary interventions cannot be released during recruitment stage but will be made public once enrollment closes.
Behavioral: dietary intervention
Research participants will be assigned to two dietary conditions.
Change in glucose tolerance from Baseline to Test Day
Change in incremental glucose area under the curve (AUC) from a mixed meal test.
Time frame: Baseline (Day 2) and Test Day (Day 4)
Changes in microbial community structure/composition/function of oral and gut microbiome from Baseline to Test Day
Shotgun metagenomics sequencing or 16S rRNA sequencing of saliva, stool, and rectal swab samples will provide in-depth interrogation of the microbial community structure, composition, and function.
Time frame: Baseline (Day 2) and Test Day (Day 4)
Change in insulin sensitivity (Oral Minimal Model method) from Baseline to Test Day
Oral Minimal Model method estimates insulin sensitivity based on blood glucose and insulin levels from a mixed meal test.
Time frame: Baseline (Day 2) and Test Day (Day 4)
Change in levels of serum markers of gut microbiota from Baseline to Test Day
Levels of markers of gut microbiota (e.g. short chain fatty acids) will be measured in serum samples taken 3-hourly over 24 hr.
Time frame: Baseline (Day 2) and Test Day (Day 4)
Change in levels of serum markers of intestinal barrier integrity from Baseline to Test Day
Levels of markers of intestinal barrier integrity (e.g. zonulin, LPS, LBP) will be measured in serum samples taken 3-hourly over 24 hr.
Time frame: Baseline (Day 2) and Test Day (Day 4)
Change in level of serum markers of inflammatory state from Baseline to Test Day
Levels of markers of inflammatory state (e.g., cytokines) will be measured in serum samples taken 3-hourly over 24 hr.
Time frame: Baseline (Day 2) and Test Day (Day 4)
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2023 (actual). Primary completion is estimated for Feb 2027, 46 months after the start.
Of 503 non-industry interventional studies with no phase under Feeding Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 46 months is above that.
Counting every sponsor, half of 515 studies reached it within 14 months; a quarter within 5 and three quarters within 31.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Sep 2026 → Feb 2027 and completion Sep 2026 → Feb 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital →